nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Sorafenib—liver cancer	0.0955	0.134	CbGbCtD
Nelfinavir—CYP3A7—Sorafenib—liver cancer	0.0706	0.0989	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0706	0.0989	CbGbCtD
Nelfinavir—CYP2B6—Sorafenib—liver cancer	0.0672	0.0941	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—liver cancer	0.058	0.0812	CbGbCtD
Nelfinavir—CYP3A5—Sorafenib—liver cancer	0.0529	0.0742	CbGbCtD
Nelfinavir—CYP2C19—Sorafenib—liver cancer	0.0427	0.0598	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—liver cancer	0.0408	0.0571	CbGbCtD
Nelfinavir—CYP1A2—Sorafenib—liver cancer	0.0394	0.0552	CbGbCtD
Nelfinavir—CYP2C9—Sorafenib—liver cancer	0.0355	0.0497	CbGbCtD
Nelfinavir—ABCB1—Sorafenib—liver cancer	0.0344	0.0483	CbGbCtD
Nelfinavir—CYP2D6—Sorafenib—liver cancer	0.0325	0.0455	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—liver cancer	0.0209	0.0293	CbGbCtD
Nelfinavir—CYP3A4—Sorafenib—liver cancer	0.0206	0.0289	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—liver cancer	0.0197	0.0276	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—liver cancer	0.0125	0.0175	CbGbCtD
Nelfinavir—Amylase increased—Sorafenib—liver cancer	0.00436	0.0299	CcSEcCtD
Nelfinavir—Suicide—Sorafenib—liver cancer	0.004	0.0274	CcSEcCtD
Nelfinavir—Completed suicide—Sorafenib—liver cancer	0.00353	0.0242	CcSEcCtD
Nelfinavir—Folliculitis—Sorafenib—liver cancer	0.0033	0.0226	CcSEcCtD
Nelfinavir—Haemoglobin decreased—Sorafenib—liver cancer	0.00301	0.0207	CcSEcCtD
Nelfinavir—Mitiglinide—PPARG—liver cancer	0.00236	0.784	CrCbGaD
Nelfinavir—Rhabdomyolysis—Sorafenib—liver cancer	0.00234	0.0161	CcSEcCtD
Nelfinavir—Opportunistic infection—Epirubicin—liver cancer	0.0019	0.013	CcSEcCtD
Nelfinavir—Mouth ulceration—Sorafenib—liver cancer	0.00188	0.0129	CcSEcCtD
Nelfinavir—Fungal skin infection—Epirubicin—liver cancer	0.00184	0.0126	CcSEcCtD
Nelfinavir—Opportunistic infection—Doxorubicin—liver cancer	0.00176	0.0121	CcSEcCtD
Nelfinavir—Fungal skin infection—Doxorubicin—liver cancer	0.0017	0.0116	CcSEcCtD
Nelfinavir—Myositis—Epirubicin—liver cancer	0.00156	0.0107	CcSEcCtD
Nelfinavir—Myositis—Doxorubicin—liver cancer	0.00145	0.00991	CcSEcCtD
Nelfinavir—Mood swings—Sorafenib—liver cancer	0.00143	0.00978	CcSEcCtD
Nelfinavir—Dehydration—Sorafenib—liver cancer	0.0014	0.0096	CcSEcCtD
Nelfinavir—Urine abnormality—Epirubicin—liver cancer	0.00138	0.00949	CcSEcCtD
Nelfinavir—Abdominal pain upper—Sorafenib—liver cancer	0.00138	0.00943	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00136	0.00929	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00133	0.0091	CcSEcCtD
Nelfinavir—Urine analysis abnormal—Epirubicin—liver cancer	0.0013	0.00894	CcSEcCtD
Nelfinavir—Urine abnormality—Doxorubicin—liver cancer	0.00128	0.00878	CcSEcCtD
Nelfinavir—Pancreatitis—Sorafenib—liver cancer	0.00128	0.00874	CcSEcCtD
Nelfinavir—Folliculitis—Epirubicin—liver cancer	0.00122	0.00836	CcSEcCtD
Nelfinavir—Myasthenia—Epirubicin—liver cancer	0.00122	0.00836	CcSEcCtD
Nelfinavir—Neutropenia—Sorafenib—liver cancer	0.00122	0.00834	CcSEcCtD
Nelfinavir—Urine analysis abnormal—Doxorubicin—liver cancer	0.00121	0.00827	CcSEcCtD
Nelfinavir—Pneumonia—Sorafenib—liver cancer	0.00117	0.008	CcSEcCtD
Nelfinavir—Jaundice—Sorafenib—liver cancer	0.00113	0.00775	CcSEcCtD
Nelfinavir—Stomatitis—Sorafenib—liver cancer	0.00113	0.00775	CcSEcCtD
Nelfinavir—Folliculitis—Doxorubicin—liver cancer	0.00113	0.00773	CcSEcCtD
Nelfinavir—Myasthenia—Doxorubicin—liver cancer	0.00113	0.00773	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Sorafenib—liver cancer	0.0011	0.00752	CcSEcCtD
Nelfinavir—Epistaxis—Sorafenib—liver cancer	0.00109	0.0075	CcSEcCtD
Nelfinavir—Hyperlipidaemia—Epirubicin—liver cancer	0.00106	0.00729	CcSEcCtD
Nelfinavir—Haemoglobin—Sorafenib—liver cancer	0.00105	0.00718	CcSEcCtD
Nelfinavir—Haemorrhage—Sorafenib—liver cancer	0.00104	0.00714	CcSEcCtD
Nelfinavir—Connective tissue disorder—Sorafenib—liver cancer	0.00102	0.00702	CcSEcCtD
Nelfinavir—Erythema multiforme—Sorafenib—liver cancer	0.000985	0.00675	CcSEcCtD
Nelfinavir—Hyperlipidaemia—Doxorubicin—liver cancer	0.000984	0.00674	CcSEcCtD
Nelfinavir—Angiopathy—Sorafenib—liver cancer	0.000945	0.00648	CcSEcCtD
Nelfinavir—Immune system disorder—Sorafenib—liver cancer	0.000941	0.00645	CcSEcCtD
Nelfinavir—Erythema—Sorafenib—liver cancer	0.000907	0.00621	CcSEcCtD
Nelfinavir—Malnutrition—Sorafenib—liver cancer	0.000907	0.00621	CcSEcCtD
Nelfinavir—Muscle spasms—Sorafenib—liver cancer	0.000872	0.00598	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000843	0.00578	CcSEcCtD
Nelfinavir—Anaemia—Sorafenib—liver cancer	0.000838	0.00574	CcSEcCtD
Nelfinavir—Hyperuricaemia—Epirubicin—liver cancer	0.000827	0.00566	CcSEcCtD
Nelfinavir—Leukopenia—Sorafenib—liver cancer	0.000812	0.00556	CcSEcCtD
Nelfinavir—Inflammation—Epirubicin—liver cancer	0.00079	0.00542	CcSEcCtD
Nelfinavir—Blood uric acid increased—Epirubicin—liver cancer	0.000781	0.00535	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00078	0.00535	CcSEcCtD
Nelfinavir—Myalgia—Sorafenib—liver cancer	0.000772	0.00529	CcSEcCtD
Nelfinavir—Arthralgia—Sorafenib—liver cancer	0.000772	0.00529	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000767	0.00525	CcSEcCtD
Nelfinavir—Hyperuricaemia—Doxorubicin—liver cancer	0.000765	0.00524	CcSEcCtD
Nelfinavir—Inflammation—Doxorubicin—liver cancer	0.000731	0.00501	CcSEcCtD
Nelfinavir—Thrombocytopenia—Sorafenib—liver cancer	0.000725	0.00497	CcSEcCtD
Nelfinavir—Blood uric acid increased—Doxorubicin—liver cancer	0.000722	0.00495	CcSEcCtD
Nelfinavir—Skin disorder—Sorafenib—liver cancer	0.000719	0.00493	CcSEcCtD
Nelfinavir—Anorexia—Sorafenib—liver cancer	0.000706	0.00483	CcSEcCtD
Nelfinavir—Rash maculo-papular—Epirubicin—liver cancer	0.000697	0.00478	CcSEcCtD
Nelfinavir—Mouth ulceration—Epirubicin—liver cancer	0.000693	0.00475	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000674	0.00462	CcSEcCtD
Nelfinavir—Dyspnoea—Sorafenib—liver cancer	0.00066	0.00452	CcSEcCtD
Nelfinavir—Saquinavir—ALB—liver cancer	0.000653	0.217	CrCbGaD
Nelfinavir—Dyspepsia—Sorafenib—liver cancer	0.000652	0.00446	CcSEcCtD
Nelfinavir—Rash maculo-papular—Doxorubicin—liver cancer	0.000645	0.00442	CcSEcCtD
Nelfinavir—Decreased appetite—Sorafenib—liver cancer	0.000643	0.00441	CcSEcCtD
Nelfinavir—Mouth ulceration—Doxorubicin—liver cancer	0.000641	0.0044	CcSEcCtD
Nelfinavir—Diabetes mellitus—Epirubicin—liver cancer	0.00064	0.00438	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000639	0.00438	CcSEcCtD
Nelfinavir—Pain—Sorafenib—liver cancer	0.000633	0.00434	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Sorafenib—liver cancer	0.000605	0.00415	CcSEcCtD
Nelfinavir—Diabetes mellitus—Doxorubicin—liver cancer	0.000592	0.00406	CcSEcCtD
Nelfinavir—Urticaria—Sorafenib—liver cancer	0.000588	0.00403	CcSEcCtD
Nelfinavir—Body temperature increased—Sorafenib—liver cancer	0.000585	0.00401	CcSEcCtD
Nelfinavir—Abdominal pain—Sorafenib—liver cancer	0.000585	0.00401	CcSEcCtD
Nelfinavir—Dermatitis bullous—Epirubicin—liver cancer	0.000582	0.00399	CcSEcCtD
Nelfinavir—Hypoglycaemia—Epirubicin—liver cancer	0.00057	0.00391	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000557	0.00381	CcSEcCtD
Nelfinavir—Affect lability—Epirubicin—liver cancer	0.000548	0.00375	CcSEcCtD
Nelfinavir—Migraine—Epirubicin—liver cancer	0.000548	0.00375	CcSEcCtD
Nelfinavir—Hypersensitivity—Sorafenib—liver cancer	0.000545	0.00374	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—liver cancer	0.000539	0.00369	CcSEcCtD
Nelfinavir—Asthenia—Sorafenib—liver cancer	0.000531	0.00364	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—liver cancer	0.000528	0.00362	CcSEcCtD
Nelfinavir—Mood swings—Epirubicin—liver cancer	0.000527	0.00361	CcSEcCtD
Nelfinavir—Pruritus—Sorafenib—liver cancer	0.000524	0.00359	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—liver cancer	0.000518	0.00355	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000515	0.00353	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—liver cancer	0.000514	0.00352	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—liver cancer	0.000508	0.00348	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—liver cancer	0.000507	0.00347	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—liver cancer	0.000507	0.00347	CcSEcCtD
Nelfinavir—Diarrhoea—Sorafenib—liver cancer	0.000506	0.00347	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000501	0.00343	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—liver cancer	0.000491	0.00336	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000491	0.00336	CcSEcCtD
Nelfinavir—Dizziness—Sorafenib—liver cancer	0.000489	0.00335	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—liver cancer	0.000488	0.00334	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—liver cancer	0.000484	0.00332	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—liver cancer	0.000479	0.00328	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—liver cancer	0.000475	0.00326	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—liver cancer	0.000472	0.00323	CcSEcCtD
Nelfinavir—Vomiting—Sorafenib—liver cancer	0.000471	0.00322	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—liver cancer	0.00047	0.00322	CcSEcCtD
Nelfinavir—Rash—Sorafenib—liver cancer	0.000467	0.0032	CcSEcCtD
Nelfinavir—Dermatitis—Sorafenib—liver cancer	0.000466	0.0032	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000464	0.00318	CcSEcCtD
Nelfinavir—Headache—Sorafenib—liver cancer	0.000464	0.00318	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000454	0.00311	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—liver cancer	0.000454	0.00311	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—liver cancer	0.00045	0.00308	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—liver cancer	0.000448	0.00307	CcSEcCtD
Nelfinavir—Nausea—Sorafenib—liver cancer	0.00044	0.00301	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—liver cancer	0.000436	0.00299	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—liver cancer	0.000434	0.00297	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—liver cancer	0.000431	0.00296	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—liver cancer	0.000418	0.00286	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—liver cancer	0.000418	0.00286	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—liver cancer	0.000416	0.00285	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—liver cancer	0.000411	0.00282	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—liver cancer	0.000406	0.00278	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—liver cancer	0.000405	0.00277	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—liver cancer	0.000402	0.00276	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—liver cancer	0.000401	0.00275	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—liver cancer	0.000399	0.00274	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—liver cancer	0.000387	0.00265	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—liver cancer	0.000387	0.00265	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—liver cancer	0.000387	0.00265	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—liver cancer	0.000386	0.00265	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—liver cancer	0.000385	0.00264	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—liver cancer	0.000385	0.00264	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—liver cancer	0.000382	0.00262	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—liver cancer	0.00038	0.00261	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—liver cancer	0.000378	0.00259	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000375	0.00257	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—liver cancer	0.000374	0.00257	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—liver cancer	0.000372	0.00255	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—liver cancer	0.000364	0.00249	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—liver cancer	0.00036	0.00247	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—liver cancer	0.000358	0.00245	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—liver cancer	0.000357	0.00245	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—liver cancer	0.000356	0.00244	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—liver cancer	0.000356	0.00244	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—liver cancer	0.000354	0.00242	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—liver cancer	0.00035	0.0024	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—liver cancer	0.000349	0.00239	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—liver cancer	0.000348	0.00238	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—liver cancer	0.000337	0.00231	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—liver cancer	0.000335	0.0023	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—liver cancer	0.000335	0.0023	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—liver cancer	0.000333	0.00228	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—liver cancer	0.00033	0.00226	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—liver cancer	0.000324	0.00222	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—liver cancer	0.000323	0.00221	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—liver cancer	0.000322	0.00221	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—liver cancer	0.000322	0.00221	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—liver cancer	0.000311	0.00213	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—liver cancer	0.00031	0.00213	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—liver cancer	0.00031	0.00213	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—liver cancer	0.00031	0.00212	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—liver cancer	0.000308	0.00211	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—liver cancer	0.000306	0.00209	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—liver cancer	0.000302	0.00207	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—liver cancer	0.0003	0.00206	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—liver cancer	0.0003	0.00206	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—liver cancer	0.000298	0.00204	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—liver cancer	0.00029	0.00199	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—liver cancer	0.000288	0.00197	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—liver cancer	0.000287	0.00196	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—liver cancer	0.000285	0.00196	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—liver cancer	0.000285	0.00196	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—liver cancer	0.000285	0.00195	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—liver cancer	0.000284	0.00195	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000283	0.00194	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—liver cancer	0.000282	0.00193	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—liver cancer	0.00028	0.00192	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—liver cancer	0.000278	0.0019	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—liver cancer	0.000274	0.00187	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—liver cancer	0.000269	0.00184	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—liver cancer	0.000268	0.00184	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—liver cancer	0.000266	0.00182	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—liver cancer	0.000264	0.00181	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—liver cancer	0.000264	0.00181	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—liver cancer	0.000264	0.00181	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—liver cancer	0.000263	0.0018	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000262	0.0018	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—liver cancer	0.000261	0.00179	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—liver cancer	0.000261	0.00179	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—liver cancer	0.000253	0.00173	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000249	0.00171	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—liver cancer	0.000248	0.0017	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—liver cancer	0.000247	0.0017	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—liver cancer	0.000246	0.00168	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—liver cancer	0.000246	0.00168	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—liver cancer	0.000245	0.00168	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—liver cancer	0.000244	0.00167	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—liver cancer	0.000243	0.00167	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—liver cancer	0.000241	0.00165	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—liver cancer	0.000241	0.00165	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—liver cancer	0.000238	0.00163	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000236	0.00162	CcSEcCtD
Nelfinavir—Pain—Epirubicin—liver cancer	0.000234	0.0016	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000231	0.00158	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—liver cancer	0.000229	0.00157	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—liver cancer	0.000227	0.00156	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—liver cancer	0.000226	0.00155	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—liver cancer	0.000225	0.00154	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—liver cancer	0.000225	0.00154	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—liver cancer	0.000224	0.00153	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—liver cancer	0.000223	0.00153	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—liver cancer	0.00022	0.00151	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000219	0.0015	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—liver cancer	0.000217	0.00149	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—liver cancer	0.000216	0.00148	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—liver cancer	0.000216	0.00148	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—liver cancer	0.000216	0.00148	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—liver cancer	0.000209	0.00143	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000207	0.00142	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—liver cancer	0.000202	0.00138	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—liver cancer	0.000201	0.00138	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—liver cancer	0.0002	0.00137	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—liver cancer	0.0002	0.00137	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—liver cancer	0.000196	0.00134	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—liver cancer	0.000194	0.00133	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—liver cancer	0.000187	0.00128	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—liver cancer	0.000186	0.00128	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—liver cancer	0.000182	0.00124	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—liver cancer	0.000181	0.00124	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—liver cancer	0.000179	0.00123	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—liver cancer	0.000174	0.00119	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—liver cancer	0.000173	0.00119	CcSEcCtD
Nelfinavir—Rash—Epirubicin—liver cancer	0.000172	0.00118	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—liver cancer	0.000172	0.00118	CcSEcCtD
Nelfinavir—Headache—Epirubicin—liver cancer	0.000171	0.00117	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—liver cancer	0.000167	0.00115	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—liver cancer	0.000162	0.00111	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—liver cancer	0.000161	0.0011	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—liver cancer	0.00016	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—liver cancer	0.000159	0.00109	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—liver cancer	0.000159	0.00109	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—liver cancer	0.00015	0.00103	CcSEcCtD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.83e-05	0.000133	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP2E1—liver cancer	1.82e-05	0.000132	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—MTHFR—liver cancer	1.79e-05	0.000131	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP1A1—liver cancer	1.78e-05	0.00013	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2E1—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CRABP1—liver cancer	1.77e-05	0.000129	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTA4—liver cancer	1.77e-05	0.000129	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP1A1—liver cancer	1.77e-05	0.000129	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CG—liver cancer	1.76e-05	0.000128	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARA—liver cancer	1.76e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CRABP1—liver cancer	1.76e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.74e-05	0.000126	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GSTM1—liver cancer	1.73e-05	0.000126	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.73e-05	0.000126	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTA2—liver cancer	1.72e-05	0.000125	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPARG—liver cancer	1.7e-05	0.000124	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYCS—liver cancer	1.7e-05	0.000124	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HPGDS—liver cancer	1.69e-05	0.000123	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.68e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GGT1—liver cancer	1.67e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GOT1—liver cancer	1.67e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYCS—liver cancer	1.66e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTA1—liver cancer	1.66e-05	0.000121	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—MTHFR—liver cancer	1.66e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—MTHFR—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HPGDS—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP1A1—liver cancer	1.64e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NAT2—liver cancer	1.64e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GGT1—liver cancer	1.63e-05	0.000119	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GOT1—liver cancer	1.63e-05	0.000119	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARA—liver cancer	1.63e-05	0.000119	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARA—liver cancer	1.62e-05	0.000118	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.58e-05	0.000115	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.58e-05	0.000115	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.58e-05	0.000115	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALDOB—liver cancer	1.58e-05	0.000115	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GLUL—liver cancer	1.57e-05	0.000114	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CPT1B—liver cancer	1.57e-05	0.000114	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HPGDS—liver cancer	1.55e-05	0.000113	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CD—liver cancer	1.55e-05	0.000113	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.55e-05	0.000113	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HPGDS—liver cancer	1.54e-05	0.000112	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—MTHFR—liver cancer	1.53e-05	0.000112	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ALB—liver cancer	1.53e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.53e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.53e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NR1H4—liver cancer	1.52e-05	0.00011	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARA—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CRABP1—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PSMD10—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PSMA4—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTP1—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA3—liver cancer	1.49e-05	0.000109	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HMOX1—liver cancer	1.48e-05	0.000108	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PSMA4—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PSMD10—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTP1—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GOT2—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARG—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HMOX1—liver cancer	1.45e-05	0.000105	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GOT2—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.4e-05	0.000102	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CG—liver cancer	1.4e-05	0.000102	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.39e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CG—liver cancer	1.38e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PSMD10—liver cancer	1.38e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PSMA4—liver cancer	1.38e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTM1—liver cancer	1.38e-05	0.0001	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP2E1—liver cancer	1.37e-05	0.0001	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.37e-05	0.0001	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PSMA4—liver cancer	1.37e-05	9.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PSMD10—liver cancer	1.37e-05	9.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA4—liver cancer	1.36e-05	9.93e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.35e-05	9.85e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CB—liver cancer	1.35e-05	9.83e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARG—liver cancer	1.35e-05	9.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTM1—liver cancer	1.35e-05	9.8e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GOT2—liver cancer	1.34e-05	9.78e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2E1—liver cancer	1.34e-05	9.76e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARG—liver cancer	1.34e-05	9.72e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GOT2—liver cancer	1.33e-05	9.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.33e-05	9.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA2—liver cancer	1.33e-05	9.67e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.33e-05	9.65e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HPGDS—liver cancer	1.31e-05	9.56e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—liver cancer	1.31e-05	9.52e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1A1—liver cancer	1.31e-05	9.51e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.31e-05	9.5e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—liver cancer	1.29e-05	9.37e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYCS—liver cancer	1.29e-05	9.36e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA1—liver cancer	1.28e-05	9.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1A1—liver cancer	1.28e-05	9.29e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NAT2—liver cancer	1.27e-05	9.23e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.26e-05	9.21e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2E1—liver cancer	1.26e-05	9.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GGT1—liver cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GOT1—liver cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYCS—liver cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2E1—liver cancer	1.25e-05	9.12e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—liver cancer	1.24e-05	9.05e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GGT1—liver cancer	1.23e-05	8.96e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GOT1—liver cancer	1.23e-05	8.96e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CD—liver cancer	1.23e-05	8.93e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MTHFR—liver cancer	1.22e-05	8.87e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CD—liver cancer	1.22e-05	8.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDOB—liver cancer	1.22e-05	8.85e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.21e-05	8.83e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—liver cancer	1.21e-05	8.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—liver cancer	1.2e-05	8.74e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARA—liver cancer	1.19e-05	8.7e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—liver cancer	1.19e-05	8.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.19e-05	8.66e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYCS—liver cancer	1.18e-05	8.61e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.17e-05	8.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYCS—liver cancer	1.17e-05	8.53e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PSMD10—liver cancer	1.17e-05	8.52e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PSMA4—liver cancer	1.17e-05	8.52e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARA—liver cancer	1.17e-05	8.5e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GOT1—liver cancer	1.16e-05	8.45e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GGT1—liver cancer	1.16e-05	8.45e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CRABP1—liver cancer	1.16e-05	8.44e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—liver cancer	1.16e-05	8.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GGT1—liver cancer	1.15e-05	8.37e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GOT1—liver cancer	1.15e-05	8.37e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GOT2—liver cancer	1.14e-05	8.29e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—liver cancer	1.13e-05	8.25e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—liver cancer	1.13e-05	8.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HMOX1—liver cancer	1.12e-05	8.13e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—liver cancer	1.12e-05	8.13e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—liver cancer	1.11e-05	8.05e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HMOX1—liver cancer	1.09e-05	7.94e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2E1—liver cancer	1.07e-05	7.79e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—liver cancer	1.07e-05	7.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—liver cancer	1.06e-05	7.72e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—liver cancer	1.04e-05	7.59e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—liver cancer	1.04e-05	7.58e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.04e-05	7.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—liver cancer	1.03e-05	7.52e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HMOX1—liver cancer	1.03e-05	7.48e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—liver cancer	1.02e-05	7.45e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HMOX1—liver cancer	1.02e-05	7.42e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—liver cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPGDS—liver cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYCS—liver cancer	1e-05	7.29e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—liver cancer	1e-05	7.28e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—liver cancer	9.88e-06	7.19e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1A1—liver cancer	9.87e-06	7.19e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—liver cancer	9.87e-06	7.18e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GOT1—liver cancer	9.83e-06	7.16e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GGT1—liver cancer	9.83e-06	7.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—liver cancer	9.65e-06	7.03e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1A1—liver cancer	9.64e-06	7.01e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—liver cancer	9.58e-06	6.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—liver cancer	9.5e-06	6.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—liver cancer	9.2e-06	6.7e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A1—liver cancer	9.08e-06	6.61e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PSMA4—liver cancer	9.03e-06	6.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PSMD10—liver cancer	9.03e-06	6.58e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARA—liver cancer	9.03e-06	6.57e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A1—liver cancer	9e-06	6.55e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—liver cancer	9e-06	6.55e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—liver cancer	8.98e-06	6.54e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—liver cancer	8.88e-06	6.46e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—liver cancer	8.83e-06	6.43e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARA—liver cancer	8.81e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—liver cancer	8.79e-06	6.4e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GOT2—liver cancer	8.79e-06	6.4e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMOX1—liver cancer	8.71e-06	6.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—liver cancer	8.68e-06	6.32e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—liver cancer	8.46e-06	6.16e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—liver cancer	8.39e-06	6.11e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARA—liver cancer	8.3e-06	6.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2E1—liver cancer	8.26e-06	6.01e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—liver cancer	8.23e-06	5.99e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARA—liver cancer	8.23e-06	5.99e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—liver cancer	8.11e-06	5.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.11e-06	5.9e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—liver cancer	7.84e-06	5.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—liver cancer	7.73e-06	5.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYCS—liver cancer	7.73e-06	5.63e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1A1—liver cancer	7.69e-06	5.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—liver cancer	7.66e-06	5.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GGT1—liver cancer	7.59e-06	5.52e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GOT1—liver cancer	7.59e-06	5.52e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—liver cancer	7.55e-06	5.49e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—liver cancer	7.46e-06	5.43e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.39e-06	5.38e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—liver cancer	7.28e-06	5.3e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—liver cancer	7.17e-06	5.22e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—liver cancer	7.11e-06	5.18e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—liver cancer	7.05e-06	5.13e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—liver cancer	7.04e-06	5.13e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARA—liver cancer	7.04e-06	5.12e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—liver cancer	6.86e-06	5e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—liver cancer	6.81e-06	4.96e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—liver cancer	6.8e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—liver cancer	6.8e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—liver cancer	6.73e-06	4.9e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMOX1—liver cancer	6.72e-06	4.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—liver cancer	6.71e-06	4.88e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—liver cancer	6.63e-06	4.83e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—liver cancer	6.55e-06	4.77e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—liver cancer	6.52e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—liver cancer	6.46e-06	4.7e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.32e-06	4.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—liver cancer	6.26e-06	4.56e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—liver cancer	6.25e-06	4.55e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—liver cancer	6.2e-06	4.51e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—liver cancer	6.17e-06	4.49e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—liver cancer	6.12e-06	4.45e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—liver cancer	6.02e-06	4.39e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—liver cancer	6.01e-06	4.38e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A1—liver cancer	5.94e-06	4.32e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—liver cancer	5.92e-06	4.31e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—liver cancer	5.81e-06	4.23e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—liver cancer	5.78e-06	4.21e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—liver cancer	5.75e-06	4.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—liver cancer	5.53e-06	4.03e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—liver cancer	5.45e-06	3.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARA—liver cancer	5.43e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—liver cancer	5.4e-06	3.93e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—liver cancer	5.33e-06	3.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—liver cancer	5.3e-06	3.86e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—liver cancer	5.28e-06	3.84e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—liver cancer	5.23e-06	3.81e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—liver cancer	4.91e-06	3.58e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—liver cancer	4.78e-06	3.48e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—liver cancer	4.67e-06	3.4e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—liver cancer	4.65e-06	3.38e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—liver cancer	4.62e-06	3.36e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—liver cancer	4.49e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—liver cancer	4.09e-06	2.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—liver cancer	4.04e-06	2.94e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—liver cancer	3.9e-06	2.84e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—liver cancer	3.82e-06	2.78e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—liver cancer	3.61e-06	2.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—liver cancer	3.56e-06	2.59e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—liver cancer	3.53e-06	2.57e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—liver cancer	3.32e-06	2.42e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—liver cancer	3.29e-06	2.4e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—liver cancer	2.95e-06	2.15e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—liver cancer	2.88e-06	2.1e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—liver cancer	2.81e-06	2.05e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—liver cancer	2.71e-06	1.98e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—liver cancer	2.69e-06	1.96e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—liver cancer	2.3e-06	1.67e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—liver cancer	2.17e-06	1.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—liver cancer	1.77e-06	1.29e-05	CbGpPWpGaD
